
The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …

Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors. Paoletti has been …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

